Mar 5 |
Relmada Therapeutics to Participate in the Leerink Partners Global Biopharma Conference
|
Mar 4 |
Is Relmada Therapeutics (NASDAQ:RLMD) In A Good Position To Invest In Growth?
|
Feb 1 |
Relmada Therapeutics Inc CEO Sergio Traversa Acquires 100,000 Shares
|
Feb 1 |
Relmada Therapeutics And 2 Other Penny Stocks Insiders Are Buying
|
Feb 1 |
Relmada Therapeutics CEO & Director Acquires 69% More Stock
|
Jan 23 |
Relmada Therapeutics, Inc.'s (NASDAQ:RLMD) market cap touched US$109m last week, benefiting both individual investors who own 39% as well as institutions
|
Jan 14 |
Relmada: Phase 3 Data Did Not Live Up To Phase 2 Benchmark
|
Jan 5 |
Health Care Roundup: Market Talk
|
Jan 4 |
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
|
Jan 4 |
Relmada Therapeutics Provides Corporate Update
|